What KPIs should a fractional CRO own at a machine learning company in 2027?

This vs. the common alternatives

The instinct when revenue stalls at a machine learning company is to hire a VP of Sales, and for a certain kind of business that instinct is right. But the fractional CRO, the full-time VP, the sales-focused advisor, and founder-led selling are four genuinely different instruments, and the KPI set you can legitimately hand each one differs more than most boards realize.

A full-time VP of Sales owns quota attainment, rep ramp time, and activity volume. Those metrics assume a repeatable motion already exists — that there is a playbook a new rep can execute, a set of objections with known answers, and a conversion rate stable enough that hiring two more reps produces roughly twice the pipeline. At most ML companies below $5M ARR, none of those assumptions hold. Every deal has a bespoke evaluation, the objections are technical rather than commercial, and the conversion rate swings wildly depending on whether the prospect's data resembles the training distribution. Handing a VP an activity-volume KPI in that environment produces a lot of calls and very little revenue.

A fractional CRO operating ten to twenty days a month cannot own rep-level management with any credibility, and you should not ask them to. What they can own is the structural layer: stage definitions, the evaluation process, forecast discipline, deal strategy on the five or six deals that actually matter this quarter, and the retention motion for existing model subscriptions. That maps cleanly to net new ARR, GRR, and evaluation velocity. It maps badly to "did every rep make forty calls."

A sales advisor or coach — typically two to four hours a month — owns nothing. They are a sounding board. If someone is billing at advisor cadence but you have written KPIs into their agreement, one of the two things is wrong. Advisors should be measured on whether the CEO finds the conversations useful, which is a judgment call, not a metric.

Founder-led selling owns learning velocity: how many distinct ICP hypotheses were tested this quarter, how many evaluations completed, what the win/loss pattern says about which data environments the model actually wins in. Founders are the only people who can credibly change the product mid-deal, which is exactly what pre-product-market-fit ML selling requires. If your GRR is under 60%, the honest answer is that no revenue leader of any employment type will fix it — the model is losing head-to-head on customer data, and that is a product problem wearing a sales costume.

There is a fifth option that gets overlooked: a fractional RevOps lead instead of a fractional CRO. If your problem is that you genuinely do not know your GRR, cannot pull evaluation cycle time out of the CRM because the stages were never defined, and your forecast is a spreadsheet the CEO edits by hand, you have an instrumentation problem, not a leadership problem. A RevOps operator at half the cost fixes that in six weeks, and then the CRO you hire afterward inherits real numbers instead of spending their first two months building them. Companies routinely hire the CRO first and then discover they are paying senior-operator rates for data hygiene work.

The adjacent comparison worth making is to how this plays out at non-ML technical companies — developer tools, data infrastructure, security. The pattern is similar: long technical evaluations, champion-driven buying, a proof-of-concept stage where most deals die. The difference is that a database either works or it does not, whereas a model's performance is probabilistic and specific to the customer's data. That single difference is why the ML KPI set weights evaluation completion so heavily. In dev tools you lose deals to budget and priority. In ML you lose them to the model scoring 84% on the customer's data when the incumbent scores 87%.

How to choose between them

The decision is not primarily about budget. It is about whether the thing you lack is a process or a person, and whether the failure is happening before, during, or after the technical evaluation.

Start with a diagnostic pass on your last twenty opportunities. Sort them into three buckets: never reached technical evaluation, entered evaluation but never completed it, and completed evaluation but lost on price or timing. The dominant bucket tells you what to hire.

If most deals never reach evaluation, you have a top-of-funnel or qualification problem, and a fractional CRO is a reasonable fit — they can rebuild ICP definition and qualification criteria fast, and evaluation-entry rate becomes the KPI they own in month one. If most deals enter and stall, the problem is evaluation design: unclear success criteria, no agreed metric threshold before the evaluation starts, no time-box, no executive sponsor on the customer side. This is the single most common failure mode at ML companies and it is squarely fractional-CRO territory, because fixing it requires authority to change how the company sells, not just better execution of the current process. If most deals complete evaluation and lose, hire nobody yet. Go read the win/loss notes with the ML team. You are losing on the product.

Set a threshold before you start interviewing. If evaluation completion rate is under 40%, the fix is process redesign and the CRO's first ninety days should be entirely about that. Between 40% and 65%, you have a working motion that needs acceleration. Above 65% with a healthy pipeline, your constraint is probably lead volume, which is a marketing problem the CRO should not own.

One more branch worth naming: if you sell primarily through partners — a cloud marketplace, a systems integrator, an OEM embedding your model in their product — the whole KPI set shifts. Net new ARR becomes partner-sourced ARR, and evaluation velocity gets measured at the partner's customer rather than yours, which means you are now dependent on someone else's sales cycle for your leading indicator. That is a legitimate structure, but a fractional CRO with only direct-sales experience will struggle with it, and you should screen for channel background explicitly rather than assuming revenue leadership transfers.

Costs, timelines, and expected impact

Fractional CRO engagements are typically structured as a monthly retainer covering a defined number of days, plus a performance component tied to closed revenue, sometimes plus equity at earlier stages. The retainer scales with days committed and with how specialized the domain expertise is — someone who has sold ML infrastructure into regulated industries commands a different rate than a generalist SaaS leader. Rather than quote numbers that vary enormously by market and stage, the useful framing is this: price the engagement against what the incremental revenue would be worth, and against what a full-time hire loaded with benefits and equity would cost over the same period. If the fractional engagement is not obviously cheaper than a full-time hire for the first two quarters, the structure is wrong.

The performance component is where most agreements get overcomplicated. A percentage of net new ARR closed during the engagement, paid on collected revenue rather than booked revenue, is clean and aligns incentives. Avoid tying the bonus to five separate metrics with weightings — it turns into a negotiation every quarter about which number counted. If you want the CRO to care about retention as well as acquisition, the simplest structure is a modest multiplier on the acquisition bonus that only unlocks if GRR stays above an agreed floor. One gate, one number.

On timelines: expect nothing measurable in the first thirty days beyond diagnostic output. A competent fractional CRO spends month one in the CRM, on calls with the ML team, and in customer conversations, and what you get at the end is a written assessment of where deals die and what the real GRR is. Month two is process changes — stage redefinition, evaluation criteria, forecast cadence. Month three is when leading indicators start moving: evaluation entry rate, evaluation completion rate, forecast accuracy. Lagging indicators — actual net new ARR — do not move until roughly one full sales cycle after the process changes land. For an enterprise ML deal running ninety to one hundred twenty days, that means you are looking at month five or six before ARR reflects the work. Boards that expect ARR movement in quarter one will fire a good operator two months before their work pays off.

Set the expectation explicitly in the engagement agreement. Month one: baseline established and diagnostic delivered. Months two through three: process and stage changes shipped, forecast accuracy within a defined band. Months four through six: evaluation velocity and completion rate improved against baseline. Months six-plus: net new ARR. Writing that ladder down protects both sides.

The impact profile is uneven and worth being honest about. The largest single gain at most machine learning companies is not more pipeline — it is recovering the deals that already entered evaluation and quietly died. If forty prospects a year grant you data access and only fourteen complete the evaluation, the twenty-six that stalled represent revenue you already paid to acquire. Moving completion from 35% to 55% is usually cheaper and faster than increasing lead volume by the equivalent amount, and it is the work a fractional CRO is best positioned to do because it requires changing how the company sells rather than working the phones.

The second-largest gain is forecast credibility, which sounds like an internal nicety until you are raising. A CEO who can tell a Series B investor "our evaluation completion rate is 58%, our median evaluation is 34 days, and here is the cohort data behind our forecast" is telling a fundamentally different story than one presenting a pipeline number with no conversion history behind it. Instrumentation is a fundraising asset, and RevOps discipline is what produces it.

The cost that does not appear in the retainer is internal time. A fractional CRO at ten days a month needs your ML lead, your top AE, and your CEO available for real conversations, not calendar-tetris fifteen-minute slots. Budget several hours a week of internal senior time. Engagements fail more often from starvation of internal access than from the operator's capability.

Implementation and handoff details

Getting the KPIs to actually work requires instrumenting three things the average early-stage CRM does not track by default, and doing it before the CRO starts rather than making it their first project.

Define the technical evaluation stage precisely. The stage begins at a specific, verifiable event: the prospect grants access to their data, or delivers a representative sample, or signs the data-processing agreement that permits the evaluation. It is not "they seemed interested." Pick the event, document it, and make it a required field. Without this, evaluation velocity is unmeasurable and every rep interprets the stage differently.

Agree on success criteria before the evaluation begins. Written down, in the deal record: what metric, what threshold, on whose data, judged by whom, by what date. This single practice moves completion rates more than anything else, because most stalled evaluations stall from ambiguity rather than from the model underperforming. When there is no agreed threshold, "good enough" becomes a moving target the champion has to defend internally with no ammunition.

Track retention at the model or use-case level, not just the account level. A customer running three of your models who quietly stops calling one of them has churned revenue while remaining a happy logo. Account-level GRR will not show it until renewal, by which point the pattern is entrenched. If your billing is usage-based this falls out of the data naturally; if it is seat- or subscription-based, you need the ML team to expose per-model call volume to the revenue side. That plumbing is a genuine engineering ask and should be scoped early.

On tooling: you do not need a sophisticated stack for this. A properly configured stage model in Salesforce or HubSpot with timestamped stage transitions covers evaluation velocity and completion rate. Conversation intelligence — Gong, Chorus, and comparable tools — earns its cost specifically because it lets you review what actually happened in stalled evaluations rather than relying on rep recollection. Forecasting tools like Clari make sense once you have enough deal volume for the patterns to be statistically meaningful; below a certain deal count they are expensive spreadsheets. The rule of thumb is that the fractional CRO should be spending the large majority of their days on deals, evaluation design, and the ML-to-revenue translation, not building dashboards. If they are building dashboards, you hired the wrong function.

Plan the handoff from the first week. A fractional engagement that runs indefinitely has quietly become an underpaid full-time role with no succession plan. The exit condition should be written: when evaluation completion rate holds above an agreed threshold for two consecutive quarters, when forecast accuracy lands within a defined band three months running, and when a documented playbook exists that a new AE can execute, the company is ready for a full-time revenue leader and the fractional operator either steps into an advisory cadence or leaves. Documentation is part of the deliverable, not a courtesy — the playbook, the ICP definition, the evaluation criteria template, the win/loss notes, and the stage definitions all belong to you.

One adjacent dynamic worth flagging: at a machine learning company, the revenue function and the research or ML engineering function have to be structurally connected in a way that is unusual elsewhere. The evaluation criteria that sales agrees to become de facto product requirements. If the CRO commits to thresholds the model cannot hit, they have created a losing deal and a demoralized engineering team simultaneously. Good fractional operators in this space spend real time with the ML lead learning where the model is genuinely strong, and then aim the ICP at those environments rather than selling into every data shape and hoping. That translation work — turning model behavior into a targeting strategy — is the most underrated part of the job and does not show up in any KPI directly. It shows up as evaluation completion rate six months later.

Related questions

Should the fractional CRO own marketing-qualified leads?

No. MQLs and traffic belong to marketing. The CRO owns what happens after a qualified opportunity exists — evaluation design, deal strategy, forecast, and retention. Giving them an MQL target creates an incentive to redefine qualification rather than improve conversion.

What if we sell entirely through a cloud marketplace?

Then partner-sourced ARR replaces direct net new ARR, and your leading indicator becomes marketplace listing conversion plus evaluation velocity at the end customer. Screen candidates for channel and marketplace experience explicitly — it is a materially different motion from direct enterprise selling.

Can a fractional CRO run the team remotely?

Yes, and most do. What matters is presence at pipeline reviews, forecast calls, and the two or three customer conversations per quarter that decide large deals. Give them full CRM and conversation-recording access on day one or the engagement starts a month behind.

How do we tell if a candidate has real ML domain experience?

Ask what they do when a prospect's evaluation comes back showing the incumbent model scoring higher. A candidate with real experience describes a specific approach — segmenting to where their model wins, renegotiating the success criteria, or walking away. A generalist describes overcoming an objection.

Does customer success report to the fractional CRO?

Usually not. CS typically reports to the CEO or a dedicated leader while the CRO holds a dotted line, because GRR is a shared number. If the CRO owns GRR outright but has no authority over CS, write the escalation path into the agreement.

FAQ

How many KPIs should a fractional CRO actually own?

Three, with a small set of diagnostic sub-metrics underneath them. Net new ARR or deployed-model revenue, gross revenue retention at the model level, and evaluation velocity. Under those sit evaluation entry rate, evaluation completion rate, and forecast accuracy — watched weekly, but not compensated on. The failure mode with a twenty-metric scorecard is that nothing is genuinely owned; every miss has four explanations sitting next to it.

Why is gross revenue retention weighted so heavily at a machine learning company?

Because model substitution is easier and less visible than software substitution. A customer can route a use case to a competing model or an in-house replacement without a migration project, without changing vendors on paper, and without telling you. Account-level retention hides this entirely. Model-level or use-case-level GRR is the only view that surfaces silent churn early enough to act on it.

What is a reasonable evaluation velocity target?

It depends on deal size and data sensitivity, but the more useful practice is to set the target against your own measured baseline rather than an external benchmark. Measure the median days from data access to decision across your last twenty evaluations, then target a meaningful reduction. Chasing a number from someone else's business tells you nothing about whether your process improved.

Should the fractional CRO's bonus include a retention component?

Yes, but structured as a gate rather than a separate weighted metric. Pay the acquisition bonus on collected revenue, and make the full payout conditional on GRR holding above an agreed floor. This prevents the classic failure where a revenue leader closes poorly-fit accounts that churn six months after their engagement ends.

When should we replace the fractional CRO with a full-time hire?

When the motion is repeatable enough that a new AE can execute a documented playbook and hit quota within a normal ramp period, and when deal volume exceeds what a part-time leader can meaningfully influence. Both conditions matter. Volume alone without a playbook means you would be hiring a full-time VP to do the same invention work at three times the cost.

Is a fractional RevOps hire a substitute or a complement?

Complement, and often the correct first hire. If nobody can tell you your current GRR or median evaluation length without a week of manual work, a RevOps operator fixes that faster and cheaper than a CRO will. The CRO then inherits working instrumentation instead of spending their first two months building it, which is an expensive way to buy a dashboard.

Sources

• Harvard Business Review — sales leadership and organizational design
• First Round Review — early-stage go-to-market and hiring
• SaaStr — SaaS metrics, retention, and revenue leadership
• Pavilion — community and resources for revenue leaders
• RevOps Co-op — revenue operations practices and benchmarking
• a16z — enterprise and AI go-to-market analysis
• Bessemer Venture Partners — cloud and AI business metrics research
• OpenView Partners — SaaS benchmarks and expansion metrics

Related on PULSE

• What should an SMB company look for in a fractional CRO in 2027?
• Is there a fractional CRO available near me in Boise in 2027?
• Is there a fractional CRO available near me in Massachusetts in 2027?
• Is there a fractional Chief Revenue Officer available near me in Detroit in 2027?
• Who is the best fractional Chief Revenue Officer in Middletown in 2027?
• Is there a fractional CRO available near me in Pasadena in 2027?